logo-loader
NASDAQ:AIDX

20/20 BioLabs Inc

Receive alerts
Market:
NASDAQ
Price
0.19 USD
Day Change
-1.01%
Market Cap:
$2.6 m
52 weeks high
50.00
52 weeks low
0.18

In brief

20/20 BioLabs develops and commercializes cutting-edge, AI-powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.

The company's advanced diagnostics leverage machine learning algorithms built on extensive real-world data, offering exceptional accuracy and convenience for individuals and providers.